ASSET | DATE | % RETURN |
---|---|---|
VirTra (VTSI) | 8/1/2008 - 8/31/2009 | 2,650% |
Cemtrex (CETX) | 8/1/2008 - 8/31/2009 | 1,628.33% |
Vanda Pharmaceuticals (VNDA) | 8/1/2008 - 8/31/2009 | 1,239.22% |
Nixxy (NIXX) | 8/1/2008 - 8/31/2009 | 903.61% |
Achieve Life Sciences (ACHV) | 8/1/2008 - 8/31/2009 | 758.12% |
IT Tech Packaging (ITP) | 8/1/2008 - 8/31/2009 | 516.66% |
Radian (RDN) | 8/1/2008 - 8/31/2009 | 400.36% |
Travere Therapeutics (TVTX) | 8/1/2008 - 8/31/2009 | 400% |
Lineage Cell Therapeutics (LCTX) | 8/1/2008 - 8/31/2009 | 384.13% |
Alpha Pro Tech (APT) | 8/1/2008 - 8/31/2009 | 380.58% |
Celsius (CELH) | 8/1/2008 - 8/31/2009 | 335.97% |
Comstock Holding Companies (CHCI) | 8/1/2008 - 8/31/2009 | 322.22% |
Intrusion (INTZ) | 8/1/2008 - 8/31/2009 | 320.45% |
Perion Network (PERI) | 8/1/2008 - 8/31/2009 | 277.71% |
BioCryst Pharmaceuticals (BCRX) | 8/1/2008 - 8/31/2009 | 270.03% |
Nephros (NEPH) | 8/1/2008 - 8/31/2009 | 243.64% |
MEDIFAST (MED) | 8/1/2008 - 8/31/2009 | 241.45% |
CryoCell International (CCEL) | 8/1/2008 - 8/31/2009 | 241.18% |
ZW Data Action Technologies (CNET) | 8/1/2008 - 8/31/2009 | 230% |
QXO (QXO) | 8/1/2008 - 8/31/2009 | 225% |
Kaival Brands Innovations (KAVL) | 8/1/2008 - 8/31/2009 | 223.53% |
Titan Pharmaceuticals (TTNP) | 8/1/2008 - 8/31/2009 | 219.15% |
BioRestorative Therapies (BRTX) | 8/1/2008 - 8/31/2009 | 212.5% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 8/1/2008 - 8/31/2009 | 203.6% |
Sobr Safe (SOBR) | 8/1/2008 - 8/31/2009 | 200% |